STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about JCAP
Insiders, 180 days
-$1.3M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.3M
2 notices
Jefferson Capital, Inc. / DE insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Jefferson Capital, Inc. / DE insiders sold a net $1.3M of stock across 7 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 27, 2025.
The trade is 33.6% of the 32,721,808 shares held after it.
1 other insider sold within 30 days.
Insider activity: Insider JCF Associates IV L.P. sold about $215.9M of JCAP on Jan 9, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 11.2% of the 3,777,500 shares held after it.
1 other insider sold within 30 days.
Insider activity: SEE REMARKS Burton David M. sold about $6.4M of JCAP on Jun 27, 2025, the largest insider sale at the company on our record; 1 other insider sold within 30 days.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
JCAP planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Person Penelope JoAnn
Filed 2026-08-25
$5.4K
Zellmann Mark Joseph
Filed 2026-08-17
$1.3M
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.3M sold by insiders over 180 days, $1.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$659.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM JCAP
FY Dec 2025
$613.3M
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
$177.5M
Mar 2026
$176.4M
Dec 2025
$154.8M
Sep 2025
$150.8M
Jun 2025
$152.7M
Mar 2025
$154.9M
Dec 2024
$119.0M
Sep 2024
$110.6M
At each fiscal year end
Single quarter
Net margin, TTM
+23.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM JCAP
FY Dec 2025
+30.6%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
+23.3%
Mar 2026
+21.3%
Dec 2025
+24.4%
Sep 2025
+25.4%
Jun 2025
+31.2%
Mar 2025
+41.5%
Dec 2024
+22.7%
Sep 2024
+33.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM JCAP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
$63.0M
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
$7.6M
At each fiscal year end
Single quarter
Debt to equity
3.68x
long-term debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity JCAP
FY Dec 2025
3.68x
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
3.68x
Mar 2026
3.96x
Dec 2025
3.68x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.13x
TTM operating cash flow over long-term debt only, 2025-12-31 (6 months older than the period end)
Cash flow to debt JCAP
FY Dec 2025
0.15x
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
0.13x
Mar 2026
0.15x
Dec 2025
0.15x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+35.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity JCAP
FY Dec 2025
+43.8%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
+35.0%
Mar 2026
+36.8%
Dec 2025
+43.8%
Sep 2025
+43.1%
Jun 2025
+45.4%
Mar 2025
+41.7%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+8.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets JCAP
FY Dec 2025
+10.0%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
+8.1%
Mar 2026
+7.7%
Dec 2025
+10.0%
Sep 2025
+9.8%
Jun 2025
+9.9%
Mar 2025
+9.7%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+11.2%
operating income after a 20.1% effective tax rate, over long-term debt only, 2025-12-31 (6 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital JCAP
FY Dec 2025
+12.6%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
+11.2%
Mar 2026
+11.3%
Dec 2025
+12.6%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed JCAP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.43x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing JCAP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
21.40x
Mar 2026
1.13x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.9B
market value at close 2026-10-23 on 2026-08-13 shares, plus long-term debt only, 2025-12-31 (6 months older than the period end), minus cash 2026-06-30
Enterprise value JCAP
FY Dec 2025
$3.0B
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
$2.8B
Mar 2026
$2.8B
Dec 2025
$3.0B
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield JCAP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
no prior four-quarter EPS window to measure growth
PEG, trailing JCAP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
JCAP ranks highest on growth (75th percentile) and profitability (68th), and lowest on insider conviction (22nd), among Financial Services peers.
Profitability
68
Inputs
Return on equity+35.0% · 91 pct, sector of 205
Return on assets+8.1% · 78 pct, sector of 266
Return on invested capital+11.2% · 34 pct, sector of 30
Return on capital employedassets or current liabilities not filed
Financial health
33
Inputs
Debt to equity3.68x · 9 pct, sector of 181
Cash flow to debt0.13x · 57 pct, sector of 141
Growth
75
Inputs
Revenue growth, YoY+41.5% · 75 pct, sector of 245
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
22
Inputs
Net Form 4 buying (codes P and S), 180d-$1.3M · 45 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Risk and compliance
40
Inputs
Short interest, % of float+5.3% · 40 pct, sector of 390
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
JCAP filings, in plain words
Are Jefferson Capital, Inc. / DE insiders buying or selling JCAP?
In the 180 days to 2026-10-27, Jefferson Capital, Inc. / DE insiders were net sellers, a net $1.3M across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of JCAP?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.3M of stock; the latest, by Person Penelope JoAnn, was filed 2026-08-25.
Read the full summary
In the 180 days to 2026-10-27, Jefferson Capital, Inc. / DE insiders were net sellers of JCAP, a net $1.3M across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.